Stem Point Capital LP Zai Lab LTD Transaction History
Stem Point Capital LP
- $499 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding ZLAB
# of Institutions
156Shares Held
34.2MCall Options Held
172KPut Options Held
217K-
Capital World Investors Los Angeles, CA6.08MShares$132 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.52MShares$76.5 Million0.09% of portfolio
-
Rtw Investments, LP New York, NY2.29MShares$49.8 Million1.04% of portfolio
-
Janus Henderson Group PLC London, X02.05MShares$44.6 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA1.72MShares$37.4 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.13B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...